CSC takes a piece of biopharm

Computer Sciences Corp. acquired Porton International Inc.'s interest in biopharmaceutical company DynPort Vaccine Company LLC for an undisclosed sum.

Previously a joint venture of CSC and biotechnology company Porton International, DVC of Frederick, Md., is part of CSC's enforcement, security and intelligence organization, which the El Segundo, Calif., company created two years ago to support programs that enhance U.S. security.

DVC specializes in developing biodefense products and has been the prime systems contractor for the Defense Department's Joint Vaccine Acquisition Program since 1997. Products in development at DVC include vaccines for botulism neurotoxin, tularemia, Venezuelan equine encephalitis, anthrax and plague.

 

Reader Comments

Please post your comments here. Comments are moderated, so they may not appear immediately after submitting. We will not post comments that we consider abusive or off-topic.

Please type the letters/numbers you see above

What is your e-mail address?

My e-mail address is:

Do you have a password?

Forgot your password? Click here
close
SEARCH
contracts DB

Trending

  • Dive into our Contract Award database

    In an exclusive for WT Insider members, we are collecting all of the contract awards we cover into a database that you can sort by contractor, agency, value and other parameters. You can also download it into a spreadsheet. Read More

  • Is SBA MIA on contractor fraud? Nick Wakeman

    Editor Nick Wakeman explores the puzzle of why SBA has been so silent on the latest contractor fraud scandal when it has been so quick to act in other cases. Read More

Webcasts

  • How Do You Support the Project Lifecycle?

    How do best-in-class project-based companies create and actively mature successful organizations? They find the right mix of people, processes and tools that enable them to effectively manage the project lifecycle. REGISTER for this webinar to hear how properly managing the cycle of capture, bid, accounting, execution, IPM and analysis will allow you to better manage your programs to stay on scope, schedule and budget. Learn More!

  • Sequestration, LPTA and the Top 100

    Join Washington Technology’s Editor-in-Chief Nick Wakeman as he analyzes the annual Top 100 list and reveals critical insights into how market trends have impacted its composition. You'll learn what movements of individual companies means and how the market overall is being impacted by the current budget environment, how the Top 100 rankings reflect the major trends in the market today and how the biggest companies in the market are adapting to today’s competitive environment. Learn More!